Ribavirin oral tablet is available only as a generic drug. Ribavirin comes as an oral tablet, oral capsule, oral solution, and inhalant solution. Ribavirin oral tablet is used in combination with ...

Ribavirin, the nucleoside analog 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, is a broad spectrum direct antiviral agent. This drug was discovered more than 40 years ago and is efficient both in ...

In clinical trials, treatment with a combination of the nucleotide polymerase inhibitor sofosbuvir and the antiviral drug ribavirin was associated with high response rates among patients with ...

Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a purine analogue and a commonly used antiviral agent against both RNA and DNA viruses. With up to five suggested mechanisms of action, ...

Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) ...

Background and Aim: Current practice guidelines recommend that individuals chronically infected with the hepatitis C virus (HCV) be treated with pegylated interferon plus ribavirin. Ribavirin, however ...

Learn everything you need to know about Ribavirin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

The dramatic outbreak of severe acute respiratory syndrome (SARS) has led to the use of high-dose intravenous and oral ribavirin in patients affected with this disorder. Ribavirin, a nucleoside ...

Review the side-effects of Ribavirin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Medications for hepatitis C vary based on the virus’s genotype and the amount of liver scarring a person has, making it crucial to identify the specific genotype for effective treatment. Combination ...

J Gastroenterol Hepatol. 2008;23(6):844-855. Recent studies have tested whether treatment of CHC patients with ribavirin alone increases virus mutation rates. In a randomized, placebo-controlled trial ...